Für diese Kanzlei können nur begrenzte Informationen angezeigt werden. Für die folgenden Kanzleien werden vollständigere Informationen angezeigt:

O'Melveny‘s life science team advises on a range of matters pertaining to the life sciences, including regulatory challenges, class actions and IP litigation and transactions, with the firm maintaining particularly strong ties to the Chinese market and overseeing a range of cross-border deals. Steve Brody is a Washington DC-based specialist in product liability and mass tort claims concerning medical device marketing, false claims and more, while New York’s Lisa Pensabene takes the lead on IP litigation, offering a ’strong grasp on patent law’ in disputes concerning cancer, HIV and neurological treatments. Government investigations and False Claims Act matters fall under the remit of Ross Galin, also based in New York and providing advice on criminal proceedings. Operating out of Los Angeles, Richard Goetz‘s litigation practice encompasses false advertising, improper labelling, personal injury and defective manufacturing claims. Hassen Sayeed is a patent litigator specializing in Hatch-Waxman and BPCI Act disputes.
Legal 500 redaktioneller Kommentar

Referenzen

Unabhängig vom Legal 500-Forschungsteam zusammengestellt.

  • 'They really understand the science and dig into the details. They were able to uncover new arguments and strategies based on their approach and understanding.'
  • 'Lisa Pensabene is a client-focused lawyer with the chops for litigation. She ensures her clients are informed and involved with shaping case direction and strategy. These strengths pair nicely with her strong grasp on patent law and ability to simplify difficult issues.'

Kernmandanten

  • AbbVie
  • Acotec Scientific Holdings Limited

Highlight-Mandate

  • Represented C.R. Bard against competitor AngioDynamics, which accused Bard of violating the Sherman Act.
  • Secured a $39m jury award for Duke University and Allergan in a patent infringement case brought against defendant Sandoz concerning a patent covering the hair growth drug Latisse.